with Hugo Gagnon, PhD, Chief Scientific Officer, Allumiqs
In this episode, we take a deep dive into what gene editing is and uncover why establishing analytics for gene editing is such a complex task.
Subscribe today for exclusive access to full episodes and stay updated on new releases.
with Kristen Nields, PhD, Senior Scientist, Janssen
In this episode, we explore the challenges in charge variant analysis and how to address the bottlenecks with new workflow approaches.
with Jill Bradley-Graham, PhD, Senior Scientist, Gene and Cell Therapy BioAnalytics, Sanofi
In this episode, we discuss why viral vector characterization is particularly challenging and how collaboration is key for newly emerging fields.
with Jérémie Parot, PhD, Research Scientist, SINTEF
In this episode, we explore the difficulties faced when characterizing mRNA and the opportunities that mRNA research brings to medicine.
with Tyler Heibeck, PhD, Principal Scientist, Sutro Biopharma
In this episode, we talk about the surprises and challenges encountered in drug development and how new analytical approaches may help find the answer.
with Shane Karnik, Senior Laboratory Director, Aliri Bioanalysis
In this episode, we discuss what bioanalysis is and how bioanalysis of oligonucleotides differs from that of other modalities.
with Thomas Kofoed, PhD, Co-founder and CEO, Alphalyse
In this episode, we chat about host cell proteins (HCPs), the importance of their analysis in cell and gene therapy products and the challenges of this field.